AI Science Tracker
EN

Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, P.R. China

1 discovery from 2025

Discoveries

Integrative multi-omics analysis proposes a metabolic classification of gliomas: distinct metabolic states, immune infiltration, and prognosis.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Multi-omics and machine learning define glioma metabolic subtypes, with metabolomic and single-nucleus RNA-seq data supporting differences in metabolic states, immune infiltration and prognosis. This is a specific measured multi-omics characterization, with observational limits.

Technology: Multi-omics clustering and machine learning define glioma metabolic subtypes, compared with metabolomic and single-nucleus RNA evidence.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Multi-omics clustering and machine learning define glioma metabolic subtypes, compared with metabolomic and single-nucleus RNA evidence.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s12967-025-07602-z

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.